There were no statistical differences among three groups in terms of sex, age, BMI, tobacco use, alcohol abuse, coronary atherosclerotic heart disease (CAD) history, dyslipidemia history, metformin use, GLP-1 RA, SGLT2i or lipid-lowering therapy. This evidence concerns the gene GLP1R and metabolic syndrome.